首页> 美国卫生研究院文献>PLoS Clinical Trials >Regression of fibrosis by cilostazol in a rat model of thioacetamide-induced liver fibrosis: Up regulation of hepatic cAMP, and modulation of inflammatory, oxidative stress and apoptotic biomarkers
【2h】

Regression of fibrosis by cilostazol in a rat model of thioacetamide-induced liver fibrosis: Up regulation of hepatic cAMP, and modulation of inflammatory, oxidative stress and apoptotic biomarkers

机译:西洛他唑在硫代乙酰胺诱导的肝纤维化大鼠模型中使纤维化消退:肝脏cAMP的上调,并调节炎症,氧化应激和凋亡生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In liver fibrosis, conversion of fibroblasts to profibrogenic myofibroblasts significantly drives the development of the disease. A crucial role of cyclic adenosine monophosphate (cAMP) in regulation of fibroblast function has been reported. Increase in cAMP levels has been found to decrease fibroblast proliferation, inhibit their conversion to myofibroblast, and stimulate their death. cAMP is generated by adenyl cyclase (AC), and degraded by cyclic nucleotide phosphodiesterase (PDE). In this study, the antifibrotic effect of a PDE inhibitor, cilostazol (Cilo), on a rat model of liver fibrosis induced by thioacetamide (TAA) was investigated. Four groups of rats were used; the first group received the vehicles and served as the normal control group, while liver fibrosis was induced in the other groups using (TAA, 200 mg/kg/biweekly for 8 successive weeks, ip). The last two groups were treated with Cilo (50 and 100 mg/kg/day, po, respectively). Induction of liver fibrosis in TAA-treated rats was observed as evidenced by the biochemical and histopathological findings. On the other hand, a potent antifibrotic effect was observed in the groups treated with Cilo, with preference to the higher dose. In these groups, a significant increase in the liver content of cAMP was demonstrated that was accompanied by reduction in the hepatic expression of key fibrogenic cytokines, growth factors, and inflammatory biomarkers, including interleukin-6, tumor necrosis factor-alpha, nuclear factor kappa B, and transforming growth factor-beta as compared to TAA group. Moreover, amelioration of TAA-induced oxidative stress and apoptosis in the liver has been observed. These findings reveal the antifibrotic effect of Cilo against TAA-induced liver fibrosis in rats, and suggest regulation of cAMP pathway, together with the modulation of oxidative stress, inflammation, and apoptosis as mechanistic cassette underlines this effect.
机译:在肝纤维化中,成纤维细胞向成纤维原性成肌纤维细胞的转化显着推动了疾病的发展。环状单磷酸腺苷(cAMP)在成纤维细胞功能调节中的关键作用已有报道。已经发现提高cAMP水平可减少成纤维细胞增殖,抑制其转化为成肌纤维细胞并刺激其死亡。 cAMP由腺苷酸环化酶(AC)生成,并被环状核苷酸磷酸二酯酶(PDE)降解。在这项研究中,研究了PDE抑制剂西洛他唑(Cilo)对硫代乙酰胺(TAA)诱导的大鼠肝纤维化的抗纤维化作用。使用四组大鼠。第一组接受媒介物并作为正常对照组,而其他组使用(TAA,200 mg / kg / biweek,连续8周,ip)诱导肝纤维化。后两组分别接受西洛(Cilo)治疗(分别口服50和100 mg / kg /天,口服)。生化和组织病理学发现证实了在接受TAA治疗的大鼠中肝纤维化的诱导。另一方面,在用Cilo治疗的组中观察到有效的抗纤维化作用,优选较高剂量。在这些组中,证明了肝脏中cAMP含量的显着增加,同时伴随着肝纤维化关键纤维生成细胞因子,生长因子和炎性生物标志物(包括白细胞介素6,肿瘤坏死因子-α,核因子κ)的肝表达降低。 B,与TAA组相比,转化生长因子-β。此外,已经观察到TAA诱导的氧化应激和肝细胞凋亡的改善。这些发现揭示了Cilo对大鼠TAA诱导的肝纤维化的抗纤维化作用,并暗示了cAMP通路的调节以及氧化应激,炎症和细胞凋亡的调节,因为机械盒强调了这种作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号